Cite
HARVARD Citation
Ibrahim, M. et al. (2016). ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. Journal of thoracic oncology. 11 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ibrahim, M. et al. (2016). ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. Journal of thoracic oncology. 11 (12), p. . [Online].